J9070 – Cyclophosphamide, 100 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ9070
- Long description
- Cyclophosphamide, 100 mg
- Short description
- Cyclophosphamide 100 mg inj
- Pricing indicator
51Drugs- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1DChemotherapy- Added
- January 1, 1984
- Last change
- April 1, 2024 – No change
- Termination date
- March 31, 2024
Frequently asked questions
What is HCPCS code J9070?
J9070 is a HCPCS Level II code for cyclophosphamide, 100 mg. It was discontinued on March 31, 2024.
Does Medicare cover J9070?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J9059 – Injection, bendamustine hydrochloride (baxter), 1 mg
- J9060 – Injection, cisplatin, powder or solution, 10 mg
- J9061 – Injection, amivantamab-vmjw, 2 mg
- J9062 – Injection, amivantamab 5 mg and hyaluronidase-lpuj
- J9063 – Injection, mirvetuximab soravtansine-gynx, 1 mg
- J9064 – Injection, cabazitaxel (sandoz), not therapeutically equivalent to j9043, 1 mg
- J9065 – Injection, cladribine, per 1 mg
- J9066 – Injection, bendamustine hydrochloride (avyxa), 1 mg
- J9071 – Injection, cyclophosphamide (auromedics), 5 mg
- J9072 – Injection, cyclophosphamide (frindovyx), 5 mg
- J9073 – Injection, cyclophosphamide (dr. reddy's), 5 mg
- J9074 – Injection, cyclophosphamide (sandoz), 5 mg
- J9075 – Injection, cyclophosphamide, not otherwise specified, 5 mg
- J9076 – Injection, cyclophosphamide (baxter), 5 mg
- J9098 – Injection, cytarabine liposome, 10 mg
- J9100 – Injection, cytarabine, 100 mg
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.